Yun Xiang Zhu
Corporate Officer/Principal bij CANBRIDGE PHARMACEUTICALS INC.
Profiel
Yun Xiang Zhu is currently the Vice President & Head-Global Research at CANbridge Pharmaceuticals Inc. Prior to this, he was the Senior Vice President at Shenogen Pharma Group Ltd.
from 2018 to 2020 and the Senior Director at Genzyme Corp.
from 2001 to 2018.
He also worked as a Research Associate at Fudan University from 1988 to 1990.
Dr. Zhu received his undergraduate degree from Zhejiang University in 1984, his graduate degree from Shanghai Institute of Materia Medica Chinese Academy of Sci in 1988, and his doctorate from The University of Miami Leonard M.
Miller School of Medicine in 1996.
Actieve functies van Yun Xiang Zhu
| Bedrijven | Functie | Begin |
|---|---|---|
| CANBRIDGE PHARMACEUTICALS INC. | Corporate Officer/Principal | 15-09-2020 |
Eerdere bekende functies van Yun Xiang Zhu
| Bedrijven | Functie | Einde |
|---|---|---|
Shenogen Pharma Group Ltd.
 Shenogen Pharma Group Ltd. Pharmaceuticals: MajorHealth Technology Shenogen Pharma Group Ltd. manufactures pharmaceutical products. It develops therapeutics for cancer treatment. The firm’s product pipeline consists of novel small molecule and antibody therapeutics for cancer treatment which includes liver cancer, breast cancer, other solid tumors and leukemia. The company was founded by Kun Meng, Jing Li, Karen Liu and Zhaoyi Wang in 2006 and is headquartered in Beijing, China. | Corporate Officer/Principal | 01-09-2020 |
Genzyme Corp.
 Genzyme Corp. Medical SpecialtiesHealth Technology Genzyme Corp. engages in development and manufacture of specialty therapeutic, surgical and diagnostic product. It serves in the areas of rare genetic diseases, multiple sclerosis, cardiovascular diseases and endocrinology. The company was founded on June 8, 1981 and is headquartered in Cambridge, MA. | Corporate Officer/Principal | 01-05-2018 |
| Fudan University | Corporate Officer/Principal | 01-08-1990 |
Opleiding van Yun Xiang Zhu
| Zhejiang University | Undergraduate Degree |
| Shanghai Institute of Materia Medica Chinese Academy of Sci | Graduate Degree |
| The University of Miami Leonard M. Miller School of Medicine | Doctorate Degree |
Ervaring
Beklede functies
Actief
Inactief
Beursgenoteerde bedrijven
Bedrijven in privébezit
Connecties
Eerstegraads connecties
Bedrijven verbonden in de eerste graad
Man
Vrouw
Besturend
Uitvoerend
Verwante bedrijven
| Beursgenoteerde bedrijven | 1 |
|---|---|
| CANBRIDGE PHARMACEUTICALS INC. | Health Technology |
| Bedrijven in privébezit | 2 |
|---|---|
Genzyme Corp.
Genzyme Corp. Medical SpecialtiesHealth Technology Genzyme Corp. engages in development and manufacture of specialty therapeutic, surgical and diagnostic product. It serves in the areas of rare genetic diseases, multiple sclerosis, cardiovascular diseases and endocrinology. The company was founded on June 8, 1981 and is headquartered in Cambridge, MA. | Health Technology |
Shenogen Pharma Group Ltd.
Shenogen Pharma Group Ltd. Pharmaceuticals: MajorHealth Technology Shenogen Pharma Group Ltd. manufactures pharmaceutical products. It develops therapeutics for cancer treatment. The firm’s product pipeline consists of novel small molecule and antibody therapeutics for cancer treatment which includes liver cancer, breast cancer, other solid tumors and leukemia. The company was founded by Kun Meng, Jing Li, Karen Liu and Zhaoyi Wang in 2006 and is headquartered in Beijing, China. | Health Technology |
